Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut

Gut Microbes

Volumn 4, Issue 4, 2013, Pages 325-339

  Groeger, David ^a   O'Mahony, Liam ^b   Murphy, Eileen F ^a   Bourke, John F ^c   Dinan, Timothy G ^d   Kiely, Barry ^a   Shanahan, Fergus ^d,e   Quigley, Eamonn M M ^d,e  

^a ALIMENTARY HEALTH LTD   (Ireland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e University College Cork and INFANT Centre   (Ireland)

Author keywords

B. infantis 35624; C reactive protein; Immunity; Inflammation; Microbiota

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM LONGUM INFANTIS; CHRONIC FATIGUE SYNDROME; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INTESTINE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PSORIASIS; ULCERATIVE COLITIS;

B. INFANTIS35624; C-REACTIVE PROTEIN; IMMUNITY; INFLAMMATION; MICROBIOTA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; BIFIDOBACTERIUM; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CYTOKINES; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; GASTROINTESTINAL TRACT; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PLACEBOS; PROBIOTICS; PSORIASIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880484582     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.25487     Document Type: Article

References (54)

1. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430:257-263; PMID:15241424; http://dx.doi.org/10.1038/nature02761
2. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010; 140:859-870; PMID:20303876; http://dx.doi.org/10.1016/j.cell.2010.01.023
3. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011; 108(SUPPL. 1):4615-4622; PMID:20660719; http://dx.doi.org/10.1073/pnas.1000082107
4. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-827; PMID:20620945; http://dx.doi.org/10.1016/j.immuni.2010.06.001
5. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species.Science 2011; 331:337-341; PMID:21205640; http://dx.doi. org/10.1126/science.1198469
6. Lyons A, O'Mahony D, O'Brien F, MacSharry J, Sheil B, Ceddia M, et al. Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 2010; 40:811-819; PMID:20067483
7. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, Lyons A, et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008; 4:e1000112; PMID:18670628; http://dx.doi.org/10.1371/journal.ppat.1000112
8. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, et al. Double blind, placebo controlled trial of two probiotic strains in interleu-kin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52:975-980; PMID:12801954; http://dx.doi.org/10.1136/gut.52.7.975
9. O'Mahony L, Feeney M, O'Halloran S, Murphy L, Kiely B, Fitzgibbon J, et al. Probiotic impact on micro-bial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001; 15:1219-1225; PMID:11472326; http://dx.doi.org/10.1046/j.1365-2036.2001.01027.x
10. McKernan D P, Fitzgerald P, Dinan TG, Cryan J F. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010; 22:1029-1035, e268; PMID:20518856; http://dx.doi.org/10.1111/j.1365-2982.2010.01520.x
11. Konieczna P, Akdis CA, Quigley EM, Shanahan F, O'Mahony L. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 2012; 3:261-266; PMID:22572827; http://dx.doi.org/10.4161/gmic.20358
12. Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F, et al. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012; 61:354-366; PMID:22052061; http://dx.doi.org/10.1136/gutjnl-2011-300936
13. Eisenhardt SU, Thiele JR, Bannasch H, Stark GB, Peter K. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 2009; 8:3885-3892; PMID:19887916; http://dx.doi.org/10.4161/cc.8.23.10068
14. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012; 61:78-85; PMID:21940721; http://dx.doi.org/10.1136/gutjnl-2011-300370
15. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55:426-431; PMID:16474109; http://dx.doi.org/10.1136/gut.2005.069476
16. Raison CL, Lin JM, Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun 2009; 23:327-337; PMID:19111923; http://dx.doi.org/10.1016/j.bbi.2008.11.005
17. Spence VA, Kennedy G, Belch JJ, Hill A, Khan F. Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clin Sci (Lond) 2008; 114:561-566; PMID:18031285; http://dx.doi.org/10.1042/CS20070274
18. Biljan D, Situm M, Kostović K, Batinac T, Matisić D. Acute phase proteins in psoriasis. Coll Antropol 2009; 33:83-86; PMID:19408608
19. Gisondi P, Malerba M, Malara G, Puglisi Guerra A, Sala R, Radaeli A, et al. C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis. Int J Immunopathol Pharmacol 2010; 23:1195-1202; PMID:21244768
20. Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Am J Clin Dermatol 2010; 11:423-432; PMID:20429617; http://dx.doi.org/10.2165/11319310-000000000-00000
21. Baran W, Szepietowski JC, Mazur G, Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol 2008; 88:113-116; PMID:18311435; http://dx.doi.org/10.2340/00015555-0427
22. Turner D, Mack DR, Hyams J, LeLeiko N, Otley A, Markowitz J, et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis 2011; 5:423-429; PMID:21939916; http://dx.doi.org/10.1016/j.crohns.2011.05.003
23. Hubacek JA, Peasey A, Pikhart H, Stavek P, Kubinova R, Marmot M, et al. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum Immunol 2010; 71:304-308; PMID:20074603; http://dx.doi.org/10.1016/j.humimm.2010.01.008
24. Macy EM, Hayes TE, Tracy R P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epide-miological applications. Clin Chem 1997; 43:52-58; PMID:8990222
25. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-1812; PMID:12813013
26. Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006; 145:35-42; PMID:16818927; http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00129
27. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al.; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-1965; PMID:11430324; http://dx.doi.org/10.1056/NEJM200106283442601
28. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh S V, O'Neil DA, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcer-ative colitis: a randomised controlled pilot trial. Gut 2005; 54:242-249; PMID:15647189; http://dx.doi.org/10.1136/gut.2004.044834
29. Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012; 35:327-334; PMID:22150569; http://dx.doi.org/10.1111/j.1365-2036.2011.04939.x.
30. Huynh HQ, deBruyn J, Guan L, Diaz H, Li M, Girgis S, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis 2009; 15:760-768; PMID:19067432; http://dx.doi.org/10.1002/ibd.20816
31. Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, et al. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005; 115:1254-1259; PMID:15940143; http://dx.doi.org/10.1016/j.jaci.2005.03.047
32. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38:611-618; PMID:18266878; http://dx.doi.org/10.1111/j.1365-2222.2008.02942.x
33. Reddy BS, Macfie J, Gatt M, Larsen CN, Jensen SS, Leser TD. Randomized clinical trial of effect of synbi-otics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing col-ectomy. Br J Surg 2007; 94:546-554; PMID:17443852; http://dx.doi.org/10.1002/bjs.5705
34. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol 2003; 32:211-215; PMID:14626627; http://dx.doi.org/10.1080/03009740310003695
35. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RM, Møller K, Svendsen KD, et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104:1831-1838; PMID:20815975; http://dx.doi.org/10.1017/S0007114510002874
36. Choi YS, Hur J, Jeong S. Beta-catenin binds to the downstream region and regulates the expression C-reactive protein gene. Nucleic Acids Res 2007; 35:5511-5519; PMID:17704137; http://dx.doi.org/10.1093/nar/gkm547
37. Feldmann M. Many cytokines are very useful therapeutic targets in disease. J Clin Invest 2008; 118:3533-3536; PMID:18982159; http://dx.doi.org/10.1172/JCI37346
38. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19:163-196; PMID:11244034; http://dx.doi.org/10.1146/annurev.immunol.19.1.163
39. Ridker PM, Cannon C P, Morrow D, Rifai N, Rose LM, McCabe CH, et al.; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352:20-28; PMID:15635109; http://dx.doi.org/10.1056/NEJMoa042378
40. Glintborg B, Østergaard M, Dreyer L, Krogh NS, Tarp U, Hansen MS, et al. Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum 2011; 63:382-390; PMID:21279995; http://dx.doi.org/10.1002/art.30117
41. Abanmi A, Al Harthi F, Al Agla R, Khan HA, Tariq M. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol 2005; 44:82-83; PMID:15663670; http://dx.doi.org/10.1111/j.1365-4632.2004.02082.x
42. Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010; 35:645-649; PMID:19843085; http://dx.doi.org/10.1111/j.1365-2230.2009.03704.x
43. Scully P, McKernan D P, Keohane J, Groeger D, Shanahan F, Dinan TG, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010; 105:2235-2243; PMID:20407431; http://dx.doi.org/10.1038/ajg.2010.159
44. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria M V, De Simone C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005; 39:540-543; PMID:15942443; http://dx.doi.org/10.1097/01.mcg.0000165671.25272.0f
45. Fukushima Y, Miyaguchi S, Yamano T, Kaburagi T, Iino H, Ushida K, et al. Improvement of nutritional status and incidence of infection in hospitalised, enter-ally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 2007; 98:969-977; PMID:17617944; http://dx.doi.org/10.1017/S0007114507764723
46. Tandon P, Moncrief K, Madsen K, Arrieta MC, Owen RJ, Bain VG, et al. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Liver Int 2009; 29:1110-1115; PMID:19490420; http://dx.doi.org/10.1111/j.1478-3231.2009.02020.x
47. Sierra S, Lara-Villoslada F, Sempere L, Olivares M, Boza J, Xaus J. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe 2010; 16:195-200; PMID:20159049; http://dx.doi.org/10.1016/j.anaerobe.2010.02.001
48. Duffin KC, Krueger GG. Genetic variations in cyto-kines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol 2009; 129:827-833; PMID:18830267; http://dx.doi.org/10.1038/jid.2008.308
49. Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med 2009; 7:96; PMID:19909538; http://dx.doi.org/10.1186/1479-5876-7-96
50. Goral V, Celenk T, Kaplan A, Sit D. Plasma cyto-kine levels in ulcerative colitis. Hepatogastroenterology 2007; 54:1130-1133; PMID:17629054
51. Federico A, Tuccillo C, Grossi E, Abbiati R, Garbagna N, Romano M, et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci 2009; 13:285-293; PMID:19694343
52. McNaught CE, Woodcock N P, Anderson AD, MacFie J. A prospective randomised trial of probiot-ics in critically ill patients. Clin Nutr 2005; 24:211-219; PMID:15784480; http://dx.doi.org/10.1016/j.clnu.2004.08.008
53. Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, et al. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 2008; 14:2029-2036; PMID:18395902; http://dx.doi.org/10.3748/wjg.14.2029
54. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A; International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-959; PMID:7978722; http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009